News | Page 3 | Office of International Affairs

Improving Care of Hospitalized Patients with HIV in Tanzania

March 11, 2024

Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost. The protocol shortened the time it took participants to attend an HIV clinic and to start on antiretroviral therapy after discharge.

However, the study published in JAMA on Mar. 6 found that the care benefits didn’t translate...

Weill Cornell Medicine Showcases Medical Education Facilities to Support Tecnológico de Monterrey’s Campus Planning

March 7, 2024

A delegation from Tecnológico de Monterrey in Mexico visited Weill Cornell Medicine on March 7, 2024, as part of the university’s planning for new academic and research facilities for its School of Medicine and Health Sciences. The delegation was led by Juan Pablo Murra, Rector of Higher Education, Dr. Luis Alonso Herrera, Dean of the School of Medicine and Health Sciences, Jessica González de Cosio, Strategic Planning Director and Health Sciences Campus Project Leader, along with other...

Drug-Resistant Tuberculosis Responds Rapidly to Bedaquiline-based Second-Line Therapy

February 27, 2024

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers at Weill Cornell Medicine in New York and GHESKIO in Haiti. Second-line medications are those that are given when one or more of the drugs given first for the disease are not effective. The research could have implications for...

Tanzania sharing information on family planning

Working with Community Leaders Boosts Family Planning in Tanzania

November 16, 2023

Researchers at Weill Cornell Medicine found that partnering with local religious leaders boosted adoption of family planning methods in Tanzania. The findings present a novel strategy for increasing global awareness and use of contraception in regions where faith leaders are trusted messengers in the community.

The study, published in The Lancet Global Health on Nov. 14, showed that...

A scientist in a lab doing research. Credit: Shutterstock

$5 Million NIH Center Grant Will Support Next Generation TB Research

September 7, 2022

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators. The New York Tri-Institutional TB Research Advancement Center (TRAC) will provide seed-funding to both early-career and established researchers new to TB science, and extend outreach...

Qatar Omicron-Wave Study Shows Slow Decline of Natural Immunity, Rapid Decline of Vaccine Immunity

June 15, 2022

A recent Pfizer or Moderna mRNA-vaccine booster provided good but temporary protection against infection by the SARS-CoV-2 omicron variant, according to a study from researchers at Weill Cornell Medicine—Qatar.

In the study, published June 15 in the New England Journal of Medicine, the researchers analyzed the omicron wave in Qatar last winter,...

Boosters Highly Effective Against COVID-19 Hospitalization and Death

March 30, 2022

Booster doses of mRNA vaccines provided strong protection against hospitalization and death from COVID-19 in Qatar, though breakthrough SARS-CoV-2 infections were greater for the omicron variant compared with the delta variant, according to a study by investigators at Weill Cornell Medicine—Qatar.

Dr. Laith Abu-Raddad, director of the WHO Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS, Sexually...

Qatar Project Highlights the Importance of Population-Specific Genetic Screening Tools for Personalized Medicine

January 19, 2022

A team led by collaborating researchers from Weill Cornell Medicine, Weill Cornell Medicine—Qatar and Qatar Foundation have assembled a large genomic database on the Qatari people, and have used it to develop an advanced but low-cost screening tool for genetic diseases in this highly distinct Middle Eastern population.

The tool, QChip1, is a microarray capable of detecting, from a blood sample, more...

Partnering with Traditional Healers Improves Uptake of HIV Tests in Rural Uganda

October 19, 2021

Collaborating with traditional healers to deliver point-of-care HIV tests to individuals in rural Uganda quadrupled testing rates compared with standard referrals to HIV clinics, according to a trial by Weill Cornell Medicine and Mbarara University of Science and Technology investigators. The healer-delivered HIV testing model has the potential to significantly improve the uptake of HIV testing among hard-to-reach populations in HIV-endemic regions of sub-Saharan Africa, as well as improve...

Study Illuminates Role of Gut Microbes in the Response to TB Treatment

March 10, 2021

Gut bacteria play an important role in the body’s response to treatment for tuberculosis (TB), according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering. Because current treatments for TB involve long courses of antibiotics, which are known to disrupt the balance of microbes in the gut, a better understanding of these interactions may help in predicting outcomes to therapy and suggest ways to improve it.

In their...